| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.07 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.08 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.086 | 0.08 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.14 | 0.08 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.094 | 0.08 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.09 |